Cadenza Bio

We are pleased to announce the esteemed members of our newly established Women’s Health Scientific Advisory Board. This initiative highlights our commitment to promoting women’s health through innovative scientific research and collaboration with leading experts in the field. #WomensHealth #ScientificAdvisoryBoard #Innovation #HealthcareLeadership #CadenzaBio #ScientificResearch #HealthEquity #MedicalAdvancement #WomenInScience #CollaborativeInnovation #MultipleSclerosis #Endometriosis #Biotechnology

Did you know that hormonal changes during menopause can exacerbate multiple sclerosis (MS) symptoms, such as fatigue and cognitive challenges, and may contribute to accelerated disease progression? However, much of the past research on MS has focused on male participants, leaving critical gaps in understanding how menopause and other gender-specific factors influence disease progression in women. Advancing research and developing personalized care strategies are crucial for addressing these disparities. By promoting equitable care, we can better support women with MS in managing their condition, enhance their quality of life, and empower the broader MS community as a whole. #MultipleSclerosis #MSAwareness #WomenWithMS #MenopauseAndMS #Menopause #MSResearch #WomensHealth #CadenzaBio

Recent research has shed light on the connection between menopause and the progression of multiple sclerosis (MS). Led by Dr. Riley Bove, MD, Associate Professor of Neurology at UCSF and member of our MS Scientific Advisory Board, the study provided key findings: ? Menopause may accelerate MS progression. ? Functional abilities, measured by MSFC performance, showed a significant decline during menopause. ? Biomarkers like serum neurofilament light chain (sNfL) levels increased, indicating potential neuronal damage. The study also examined the potential role of estrogen therapy in alleviating these effects, stressing the importance of personalized treatments for women with MS. This research marks a significant advancement in improving outcomes and quality of life for women with MS. However, further research is needed to thoroughly understand and address these findings. You can find the complete study by following the link in the comments. #MultipleSclerosis #MSResearch #MSAwareness #Neurology #Menopause #WomensHealth #HealthcareInnovation #MedicalResearch #CadenzaBio

March is not only Multiple Sclerosis Awareness Month but also Endometriosis Awareness Month, offering a valuable opportunity to raise awareness of a condition that affects 1 in 10 women of reproductive age worldwide. Endometriosis is a chronic medical condition in which tissue similar to the lining of the uterus grows outside of it, resulting in debilitating symptoms such as pelvic pain, heavy menstrual bleeding, and, in some cases, infertility. Alarmingly, many individuals encounter substantial delays in receiving a diagnosis—often waiting years, or even up to a decade, for proper answers. Several factors contribute to these diagnostic delays: ? Nonspecific or unrecognized symptoms. ? Chronic pelvic pain often dismissed as “normal” menstrual discomfort. ? Limited awareness and understanding of the condition. By improving understanding and reducing stigma, we can encourage earlier diagnoses and better healthcare for those living with endometriosis. Let’s keep this vital conversation going throughout the month and beyond.? #EndometriosisAwareness #EndometriosisMonth #WomensHealth #ChronicIllness #ReproductiveHealth #HealthAwareness #ResearchMatters #HealthAdvocacy #CadenzaBio

Elaine H., our COO, will attend BIO-Europe Spring in Milan, Italy, from March 17-19 to discuss our groundbreaking drug development advancements, including a remyelination treatment for multiple sclerosis and a lesion-reducing therapy for endometriosis. If you are attending #BIOEuropeSpring2025 or share our passion for advancing research in MS and endometriosis, we would love to connect and explore collaboration opportunities. Let’s work together to make significant progress in these critical areas of healthcare. #BIOEuropeSpring #DrugDevelopment #MultipleSclerosis #Endometriosis #Research #HealthcareInnovation #Remyelination #MedicalBreakthroughs #Collaboration #Biotech #CadenzaBio

March is MS Awareness Month – Join Us in Raising Awareness for Multiple Sclerosis! Multiple Sclerosis (MS) affects approximately 2.8 million people worldwide. This chronic neurological condition occurs when the immune system attacks the protective layer of nerves, disrupting communication between the brain and body. Common symptoms such as chronic pain, fatigue, and impaired coordination can make everyday activities—like walking, working, or speaking—extremely challenging. Despite these difficulties, individuals living with MS demonstrate remarkable resilience and strength. This month, we stand together to: ? Increase awareness about MS ? Advocate for greater understanding and support ? Advance research and improve treatments By joining forces, we can work towards a future where MS is no longer a barrier. Consider supporting trusted organizations such as the National MS Society or the MS International Federation (MSIF) to learn more and make a difference. Every effort takes us one step closer. #MSAwarenessMonth #MultipleSclerosis #Advocacy #Support #CadenzaBio #MSSociety #MSIF #ChronicIllness #NeurologicalDisorder #ResearchMatters #DisabilityAwareness #HealthAdvocacy #CureMS

Exciting progress in the fight against endometriosis! Currently, it takes an average of 7 to 10 years for women to receive a diagnosis of endometriosis, forcing millions to endure chronic pain and uncertainty. Traditionally, diagnosis has relied on invasive surgical procedures, highlighting the urgent need for improved diagnostic solutions. Serac Healthcare?is addressing this critical gap with its innovative diagnostic tool, ???Tc-maraciclatide. This non-invasive approach has the potential to deliver faster, more accurate diagnoses without the need for surgery, offering hope to countless women seeking timely and effective care. In collaboration with the FDA,?Serac Healthcare?is finalizing protocols to advance this groundbreaking tool toward widespread availability. These advancements mark a significant step forward in ensuring that women can access accurate diagnoses while avoiding years of uncertainty and invasive procedures. #EndometriosisAwareness?#WomensHealth?#MedicalInnovation?#SeracHealthcare?#Endometriosis?#CadenzaBio

We’re excited to announce that our CEO, Carol Curtis, Ph.D., will attend the Americas Committee for Treatment & Research in Multiple Sclerosis (ACTRIMS) Forum 2025 in West Palm Beach from February 27 to March 1.?This conference serves as a crucial platform for connecting with the MS community—offering an opportunity to share insights, exchange knowledge, and highlight innovative research. We're eager to share our recent advancements in developing remyelination therapies to reduce the impact of MS and learn from the broader community of experts and advocates who are advancing care and understanding in this field. Are you attending #ACTRIMS 2025? Let’s connect and explore how we can continue making strides together! #MultipleSclerosis #MSResearch #HealthcareInnovation #Neurology #MSCommunity #TherapeuticAdvancement #CadenzaBio #ACTRIMSForum?

Significant advancements in the battle against endometriosis! Cadenza Bio is partnering with Juan Gnecco, PhD at Tufts University, to develop innovative therapies for this condition, which affects 1 in 10 women. By merging our expertise in targeted therapies with the advanced organoid systems of the Gnecco Lab of Reproductive Engineering,?we expect to develop?treatments that effectively target endometriosis while maintaining reproductive function. This partnership reflects our commitment to advancing women’s health and creating innovative solutions for those impacted by this condition. Stay tuned for updates as we work toward a brighter future for those impacted by?Endometriosis! #Endometriosis #WomensHealth #CadenzaBio #Biotech #TuftsUniversity #GneccoLaboratory #ReproductiveHealth #EndometriosisAwareness

Endometriosis is a leading cause of infertility, affecting 30-50% of individuals diagnosed with the condition. This condition occurs when tissue similar to the uterine lining grows outside the uterus, often leading to pain and complications. When this tissue develops on the ovaries, fallopian tubes, or pelvic lining, it can obstruct the movement of eggs and sperm, significantly impacting conception. Raising awareness and educating individuals about endometriosis are essential for enhancing fertility outcomes and providing more comprehensive support for those affected.? Continuous focus on research and attention is crucial for attaining better care and enhanced understanding. #EndometriosisAwareness #ReproductiveHealth #Fertility #Endometriosis #CadenzaBio #WomensHealth #ChronicConditions